David Fraguas1, Covadonga M Díaz-Caneja1, Laura Pina-Camacho2, Joost Janssen3, Celso Arango4. 1. Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, CIBERSAM, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Universidad Complutense, Madrid, Spain. 2. Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, CIBERSAM, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Universidad Complutense, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, King's College London, London, UK. 3. Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, CIBERSAM, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Universidad Complutense, Madrid, Spain; Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, The Netherlands. 4. Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, CIBERSAM, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), School of Medicine, Universidad Complutense, Madrid, Spain. Electronic address: carango@hggm.es.
Abstract
BACKGROUND: Studies on longitudinal brain volume changes in patients with early-onset psychosis (EOP) are particularly valuable for understanding the neurobiological basis of brain abnormalities associated with psychosis. However, findings have not been consistent across studies in this population. We aimed to conduct a meta-analysis on progressive brain volume changes in children and adolescents with EOP. METHODS: A systematic literature search of magnetic resonance imaging (MRI) studies comparing longitudinal brain volume changes in children and adolescents with EOP and healthy controls was conducted. The annualized rates of relative change in brain volume by region of interest (ROI) were used as raw data for the meta-analysis. The effect of age, sex, duration of illness, and specific diagnosis on volume change was also evaluated. RESULTS: Five original studies with 156 EOP patients (mean age at baseline MRI in the five studies ranged from 13.3 to 16.6years, 67.31% males) and 163 age- and sex-matched healthy controls, with a mean duration of follow-up of 2.46years (range 2.02-3.40), were included. Frontal gray matter (GM) was the only region in which significant differences in volume change over time were found between patients and controls (Hedges' g -0.435, 95% confidence interval (CI): -0.678 to -0.193, p<0.001). Younger age at baseline MRI was associated with greater loss of temporal GM volume over time in patients as compared with controls (p=0.005). Within patients, a diagnosis of schizophrenia was related to greater occipital GM volume loss over time (p=0.001). CONCLUSIONS: Compared with healthy individuals, EOP patients show greater progressive frontal GM loss over the first few years after illness onset. Age at baseline MRI and diagnosis of schizophrenia appear to be significant moderators of particular specific brain volume changes.
BACKGROUND: Studies on longitudinal brain volume changes in patients with early-onset psychosis (EOP) are particularly valuable for understanding the neurobiological basis of brain abnormalities associated with psychosis. However, findings have not been consistent across studies in this population. We aimed to conduct a meta-analysis on progressive brain volume changes in children and adolescents with EOP. METHODS: A systematic literature search of magnetic resonance imaging (MRI) studies comparing longitudinal brain volume changes in children and adolescents with EOP and healthy controls was conducted. The annualized rates of relative change in brain volume by region of interest (ROI) were used as raw data for the meta-analysis. The effect of age, sex, duration of illness, and specific diagnosis on volume change was also evaluated. RESULTS: Five original studies with 156 EOP patients (mean age at baseline MRI in the five studies ranged from 13.3 to 16.6years, 67.31% males) and 163 age- and sex-matched healthy controls, with a mean duration of follow-up of 2.46years (range 2.02-3.40), were included. Frontal gray matter (GM) was the only region in which significant differences in volume change over time were found between patients and controls (Hedges' g -0.435, 95% confidence interval (CI): -0.678 to -0.193, p<0.001). Younger age at baseline MRI was associated with greater loss of temporal GM volume over time in patients as compared with controls (p=0.005). Within patients, a diagnosis of schizophrenia was related to greater occipital GM volume loss over time (p=0.001). CONCLUSIONS: Compared with healthy individuals, EOP patients show greater progressive frontal GM loss over the first few years after illness onset. Age at baseline MRI and diagnosis of schizophrenia appear to be significant moderators of particular specific brain volume changes.
Authors: Martin Rozycki; Theodore D Satterthwaite; Nikolaos Koutsouleris; Guray Erus; Jimit Doshi; Daniel H Wolf; Yong Fan; Raquel E Gur; Ruben C Gur; Eva M Meisenzahl; Chuanjun Zhuo; Hong Yin; Hao Yan; Weihua Yue; Dai Zhang; Christos Davatzikos Journal: Schizophr Bull Date: 2018-08-20 Impact factor: 9.306
Authors: Covadonga M Díaz-Caneja; Hugo Schnack; Kenia Martínez; Javier Santonja; Yasser Alemán-Gomez; Laura Pina-Camacho; Carmen Moreno; David Fraguas; Celso Arango; Mara Parellada; Joost Janssen Journal: Hum Brain Mapp Date: 2018-12-19 Impact factor: 5.038
Authors: Josefina Castro-Fornieles; Nuria Bargalló; Anna Calvo; Celso Arango; Immaculada Baeza; Ana Gonzalez-Pinto; Mara Parellada; Montserrat Graell; Carmen Moreno; Soraya Otero; Joost Janssen; Marta Rapado-Castro; Elena de la Serna Journal: Eur Child Adolesc Psychiatry Date: 2017-07-13 Impact factor: 4.785
Authors: Bo Cao; Raymond Y Cho; Dachun Chen; Meihong Xiu; Li Wang; Jair C Soares; Xiang Yang Zhang Journal: Mol Psychiatry Date: 2018-06-19 Impact factor: 15.992
Authors: Tara A Niendam; Kimberly L Ray; Ana-Maria Iosif; Tyler A Lesh; Stefania R Ashby; Pooja K Patel; Jason Smucny; Emilio Ferrer; Marjorie Solomon; J Daniel Ragland; Cameron S Carter Journal: JAMA Psychiatry Date: 2018-12-01 Impact factor: 21.596
Authors: Zainab Al-Dhaher; Sandeep Kapoor; Ema Saito; Scott Krakower; Lisa David; Theodore Ake; John M Kane; Christoph U Correll; Maren Carbon Journal: J Child Adolesc Psychopharmacol Date: 2016-04-19 Impact factor: 2.576
Authors: R Blakey; S Ranlund; E Zartaloudi; W Cahn; S Calafato; M Colizzi; B Crespo-Facorro; C Daniel; Á Díez-Revuelta; M Di Forti; C Iyegbe; A Jablensky; R Jones; M-H Hall; R Kahn; L Kalaydjieva; E Kravariti; K Lin; C McDonald; A M McIntosh; M Picchioni; J Powell; A Presman; D Rujescu; K Schulze; M Shaikh; J H Thygesen; T Toulopoulou; N Van Haren; J Van Os; M Walshe; R M Murray; E Bramon Journal: Psychol Med Date: 2017-11-02 Impact factor: 7.723